Logo image of NGVT

INGEVITY CORP (NGVT) Stock Fundamental Analysis

NYSE:NGVT - New York Stock Exchange, Inc. - US45688C1071 - Common Stock - Currency: USD

43.23  -0.86 (-1.95%)

Fundamental Rating

4

NGVT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 85 industry peers in the Chemicals industry. NGVT has an average financial health and profitability rating. NGVT scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

NGVT had positive earnings in the past year.
NGVT had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: NGVT reported negative net income in multiple years.
NGVT had a positive operating cash flow in each of the past 5 years.
NGVT Yearly Net Income VS EBIT VS OCF VS FCFNGVT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of -17.21%, NGVT is doing worse than 81.18% of the companies in the same industry.
NGVT has a worse Return On Equity (-150.81%) than 92.94% of its industry peers.
With an excellent Return On Invested Capital value of 12.56%, NGVT belongs to the best of the industry, outperforming 92.94% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for NGVT is above the industry average of 6.81%.
The last Return On Invested Capital (12.56%) for NGVT is above the 3 year average (10.65%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -17.21%
ROE -150.81%
ROIC 12.56%
ROA(3y)-4.58%
ROA(5y)-0.24%
ROE(3y)-63.66%
ROE(5y)-29.04%
ROIC(3y)10.65%
ROIC(5y)10.84%
NGVT Yearly ROA, ROE, ROICNGVT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

Looking at the Operating Margin, with a value of 21.09%, NGVT belongs to the top of the industry, outperforming 88.24% of the companies in the same industry.
NGVT's Operating Margin has declined in the last couple of years.
NGVT's Gross Margin of 34.69% is fine compared to the rest of the industry. NGVT outperforms 69.41% of its industry peers.
NGVT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 21.09%
PM (TTM) N/A
GM 34.69%
OM growth 3Y-6.17%
OM growth 5Y-4.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.27%
GM growth 5Y-2.81%
NGVT Yearly Profit, Operating, Gross MarginsNGVT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so NGVT is still creating some value.
The number of shares outstanding for NGVT has been increased compared to 1 year ago.
Compared to 5 years ago, NGVT has less shares outstanding
Compared to 1 year ago, NGVT has a worse debt to assets ratio.
NGVT Yearly Shares OutstandingNGVT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
NGVT Yearly Total Debt VS Total AssetsNGVT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 2.20 indicates that NGVT is not a great score, but indicates only limited risk for bankruptcy at the moment.
NGVT's Altman-Z score of 2.20 is in line compared to the rest of the industry. NGVT outperforms 57.65% of its industry peers.
The Debt to FCF ratio of NGVT is 14.65, which is on the high side as it means it would take NGVT, 14.65 years of fcf income to pay off all of its debts.
NGVT has a Debt to FCF ratio (14.65) which is in line with its industry peers.
A Debt/Equity ratio of 5.68 is on the high side and indicates that NGVT has dependencies on debt financing.
NGVT's Debt to Equity ratio of 5.68 is on the low side compared to the rest of the industry. NGVT is outperformed by 91.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.68
Debt/FCF 14.65
Altman-Z 2.2
ROIC/WACC1.42
WACC8.87%
NGVT Yearly LT Debt VS Equity VS FCFNGVT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

A Current Ratio of 2.00 indicates that NGVT has no problem at all paying its short term obligations.
NGVT has a Current ratio of 2.00. This is comparable to the rest of the industry: NGVT outperforms 51.76% of its industry peers.
NGVT has a Quick Ratio of 1.08. This is a normal value and indicates that NGVT is financially healthy and should not expect problems in meeting its short term obligations.
NGVT's Quick ratio of 1.08 is in line compared to the rest of the industry. NGVT outperforms 42.35% of its industry peers.
Industry RankSector Rank
Current Ratio 2
Quick Ratio 1.08
NGVT Yearly Current Assets VS Current LiabilitesNGVT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 20.90% over the past year.
Measured over the past years, NGVT shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.12% on average per year.
Looking at the last year, NGVT shows a very negative growth in Revenue. The Revenue has decreased by -17.64% in the last year.
NGVT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.70% yearly.
EPS 1Y (TTM)20.9%
EPS 3Y-11.81%
EPS 5Y-6.12%
EPS Q2Q%90.38%
Revenue 1Y (TTM)-17.64%
Revenue growth 3Y0.36%
Revenue growth 5Y1.7%
Sales Q2Q%-16.5%

3.2 Future

NGVT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.18% yearly.
NGVT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.23% yearly.
EPS Next Y21.23%
EPS Next 2Y18.67%
EPS Next 3Y17.18%
EPS Next 5YN/A
Revenue Next Year-5.89%
Revenue Next 2Y-0.73%
Revenue Next 3Y1.23%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NGVT Yearly Revenue VS EstimatesNGVT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
NGVT Yearly EPS VS EstimatesNGVT Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 10.67 indicates a reasonable valuation of NGVT.
Based on the Price/Earnings ratio, NGVT is valued cheaper than 85.88% of the companies in the same industry.
NGVT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.91.
Based on the Price/Forward Earnings ratio of 8.58, the valuation of NGVT can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NGVT indicates a rather cheap valuation: NGVT is cheaper than 85.88% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 37.11, NGVT is valued rather cheaply.
Industry RankSector Rank
PE 10.67
Fwd PE 8.58
NGVT Price Earnings VS Forward Price EarningsNGVT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NGVT indicates a somewhat cheap valuation: NGVT is cheaper than 77.65% of the companies listed in the same industry.
74.12% of the companies in the same industry are more expensive than NGVT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.57
EV/EBITDA 7.54
NGVT Per share dataNGVT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NGVT's earnings are expected to grow with 17.18% in the coming years.
PEG (NY)0.5
PEG (5Y)N/A
EPS Next 2Y18.67%
EPS Next 3Y17.18%

0

5. Dividend

5.1 Amount

No dividends for NGVT!.
Industry RankSector Rank
Dividend Yield N/A

INGEVITY CORP

NYSE:NGVT (7/30/2025, 10:42:48 AM)

43.23

-0.86 (-1.95%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners103.19%
Inst Owner Change-0.11%
Ins Owners1.03%
Ins Owner Change24.4%
Market Cap1.58B
Analysts82
Price Target52.79 (22.11%)
Short Float %3.37%
Short Ratio5.84
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)117.25%
Min EPS beat(2)31.61%
Max EPS beat(2)202.89%
EPS beat(4)3
Avg EPS beat(4)62.07%
Min EPS beat(4)-6.05%
Max EPS beat(4)202.89%
EPS beat(8)6
Avg EPS beat(8)64.28%
EPS beat(12)8
Avg EPS beat(12)41.57%
EPS beat(16)11
Avg EPS beat(16)35.74%
Revenue beat(2)0
Avg Revenue beat(2)-4.11%
Min Revenue beat(2)-5.75%
Max Revenue beat(2)-2.47%
Revenue beat(4)0
Avg Revenue beat(4)-4.53%
Min Revenue beat(4)-6.04%
Max Revenue beat(4)-2.47%
Revenue beat(8)2
Avg Revenue beat(8)-1.58%
Revenue beat(12)4
Avg Revenue beat(12)-0.92%
Revenue beat(16)8
Avg Revenue beat(16)1.42%
PT rev (1m)0%
PT rev (3m)4.02%
EPS NQ rev (1m)-0.64%
EPS NQ rev (3m)-9.18%
EPS NY rev (1m)0.12%
EPS NY rev (3m)-4.27%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.1%
Revenue NY rev (1m)0.22%
Revenue NY rev (3m)-1.88%
Valuation
Industry RankSector Rank
PE 10.67
Fwd PE 8.58
P/S 1.17
P/FCF 16.57
P/OCF 9.49
P/B 6.72
P/tB N/A
EV/EBITDA 7.54
EPS(TTM)4.05
EY9.37%
EPS(NY)5.04
Fwd EY11.66%
FCF(TTM)2.61
FCFY6.03%
OCF(TTM)4.56
OCFY10.54%
SpS37.04
BVpS6.43
TBVpS-6.11
PEG (NY)0.5
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.21%
ROE -150.81%
ROCE 15.9%
ROIC 12.56%
ROICexc 13.08%
ROICexgc 17.82%
OM 21.09%
PM (TTM) N/A
GM 34.69%
FCFM 7.04%
ROA(3y)-4.58%
ROA(5y)-0.24%
ROE(3y)-63.66%
ROE(5y)-29.04%
ROIC(3y)10.65%
ROIC(5y)10.84%
ROICexc(3y)11.07%
ROICexc(5y)11.72%
ROICexgc(3y)17.77%
ROICexgc(5y)19.74%
ROCE(3y)13.49%
ROCE(5y)13.72%
ROICexcg growth 3Y-8.19%
ROICexcg growth 5Y-5.86%
ROICexc growth 3Y-1.67%
ROICexc growth 5Y-0.8%
OM growth 3Y-6.17%
OM growth 5Y-4.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.27%
GM growth 5Y-2.81%
F-Score5
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 5.68
Debt/FCF 14.65
Debt/EBITDA 3.43
Cap/Depr 68.53%
Cap/Sales 5.26%
Interest Coverage 3.43
Cash Conversion 42.77%
Profit Quality N/A
Current Ratio 2
Quick Ratio 1.08
Altman-Z 2.2
F-Score5
WACC8.87%
ROIC/WACC1.42
Cap/Depr(3y)97.35%
Cap/Depr(5y)93.69%
Cap/Sales(3y)6.85%
Cap/Sales(5y)6.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.9%
EPS 3Y-11.81%
EPS 5Y-6.12%
EPS Q2Q%90.38%
EPS Next Y21.23%
EPS Next 2Y18.67%
EPS Next 3Y17.18%
EPS Next 5YN/A
Revenue 1Y (TTM)-17.64%
Revenue growth 3Y0.36%
Revenue growth 5Y1.7%
Sales Q2Q%-16.5%
Revenue Next Year-5.89%
Revenue Next 2Y-0.73%
Revenue Next 3Y1.23%
Revenue Next 5YN/A
EBIT growth 1Y24.1%
EBIT growth 3Y-5.83%
EBIT growth 5Y-2.78%
EBIT Next Year58.8%
EBIT Next 3Y22.73%
EBIT Next 5YN/A
FCF growth 1Y-38.13%
FCF growth 3Y-35.4%
FCF growth 5Y-20.53%
OCF growth 1Y-43.5%
OCF growth 3Y-24%
OCF growth 5Y-14.15%